Henan Taloph Pharmaceutical Stock Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 499.11 million compared to CNY 560.32 million a year ago. Revenue was CNY 499.11 million compared to CNY 560.32 million a year ago.

Net income was CNY 21.26 million compared to CNY 3.68 million a year ago. Basic earnings per share from continuing operations was CNY 0.0381 compared to CNY 0.0065 a year ago. Diluted earnings per share from continuing operations was CNY 0.0381 compared to CNY 0.0065 a year ago.